Form 4: USANA Health Sciences Executive Chairman Kevin Guest Reports Stock Transactions

Kevin Guest, Executive Chairman of USANA Health Sciences, reports transactions involving common stock and restricted stock units on February 8, 2025.

Summary

• On February 8, 2025, Kevin Guest, the Executive Chairman of the Board at USANA Health Sciences Inc., engaged in transactions involving the company's common stock and restricted stock units.
• Guest exercised 7,003 restricted stock units, acquiring 7,003 shares of common stock.
• Simultaneously, 2,966 shares were disposed of at a price of $30.65.
• Another transaction involved the exercise of 4,425 restricted stock units, resulting in the acquisition of 4,425 shares of common stock.
• Concurrently, 1,875 shares were disposed of at a price of $30.65.
• Following these transactions, Guest directly owns 27,782 shares of common stock and 43,998 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company's future prospects.

Key Dates

Keywords

USANA Health Sciences, Kevin Guest, Executive Chairman, Stock Transactions, Restricted Stock Units, Common Stock, Form 4, SEC Filing